Alphatec vs Carlsmed
ATEC and CARL side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ATEC and CARL compare
Alphatec is the larger company, worth 2.3 times as much as Carlsmed ($1.1B against $472M).
Carlsmed grew revenue faster over the last twelve months (60.4% versus 15.3% for Alphatec).
Alphatec keeps more of each dollar of sales as profit, with a net margin of −10.3% compared with −55.8% at Carlsmed.
Alphatec scores higher on the StockData Score (7 against 5 for Carlsmed), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ATEC | CARL |
|---|---|---|
| Size and price | ||
| Market cap | $1.1B | $472M |
| Share price | $7.06 | $17.30 |
| Change, 1 year | −65.9% | 42.0% |
| Change, 5 years | −37.4% | – |
| Beta (5Y) | 1.15 | 2.22 |
| Employees | 913 | 24 |
| StockData Score | ||
| Total score | 7 (better) | 5 |
| Valuation score | 1 (better) | 0 |
| Growth score | 3 | 3 |
| Performance score | 2 (better) | 0 |
| Health score | 1 | 2 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.3× (better) | 6.6× |
| P/B | – | 6.2× |
| EV/EBITDA | 40.0× | – |
| P/FCF | 357× | – |
| FCF yield | 0.28% (better) | −7.4% |
| Fair value | – | $8.30 |
| Margin of safety | – | −109% |
| Growth | ||
| Revenue growth (TTM) | 15.3% | 60.4% (better) |
| Revenue growth, 5Y average | 39.5% | – |
| Profitability | ||
| Gross margin | 71.3% | 77.0% (better) |
| Operating margin | −3.6% (better) | −59.0% |
| Net margin | −10.3% (better) | −55.8% |
| FCF margin | 0.37% (better) | −48.6% |
| Return on equity | −1888% | −43.9% (better) |
| Return on invested capital | −5.0% (better) | −953% |
| Financial health | ||
| Net debt / EBITDA | 12.06 | – |
| Interest coverage | −0.7× (better) | −33.3× |
| Current ratio | 2.36 | 5.79 (better) |
| Altman Z-score | −0.49 | 5.87 (better) |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | 0.00% |
| Ownership | ||
| Held by institutions | 72.7% | 20.9% |
| Held by insiders | 23.5% | 81.1% |
| Insider net buying, 12 months | −$40.9M | −$2.7M (better) |
| Short interest, % of float | 12.0% | 24.0% |
Go deeper
- ATEC stock overview
- ATEC income statement
- ATEC valuation and score
- CARL stock overview
- CARL income statement
- CARL valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.